<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="cause" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">3. Discussion</segment>
<segment id="2" parent="1002" relname="span">Increased selectivity and efficacy can be achieved</segment>
<segment id="3" parent="2" relname="means">by linking cytotoxic anticancer drugs to specific target/carrier molecules .</segment>
<segment id="4" parent="1004" relname="span">Successful examples of this treatment strategy are antibody-drug conjugates ,</segment>
<segment id="5" parent="1005" relname="same_unit">which target cancer cells</segment>
<segment id="6" parent="1006" relname="joint">due to increased expression of specific proteins ,</segment>
<segment id="7" parent="1007" relname="span">and folate conjugates ,</segment>
<segment id="8" parent="1008" relname="span">which utilize a commonly high expression of the folate receptor</segment>
<segment id="9" parent="8" relname="elaboration">( FR ) on the surface of different human cancer cells .</segment>
<segment id="10" parent="1003" relname="joint">Warburg effect targeting is another promising strategy for the design and synthesis of new cytotoxic anticancer drugs .</segment>
<segment id="11" parent="1003" relname="joint">Here , the conjugation of sugar residues to cytotoxic drugs shall increase selectivity to cancerous tissues</segment>
<segment id="12" parent="1012" relname="span">and reduce side effects in patients</segment>
<segment id="13" parent="12" relname="cause">due to a higher sugar uptake by the cancer cells .</segment>
<segment id="14" parent="1003" relname="joint">To date one sugar-conjugated molecule glufosfamide is in clinical development for the treatment of lung , ovary , pancreatic , brain and CNS cancer as well as soft tissue sarcoma .</segment>
<segment id="15" parent="1015" relname="preparation">In addition , different sugar-conjugated molecules are currently evaluated preclinically .</segment>
<segment id="16" parent="1017" relname="span">In prostate cancer Warburg effect was observed specifically in metastatic tumors</segment>
<segment id="17" parent="16" relname="elaboration">which makes glucose-derived chemotherapeutics promising in the treatment of metastatic CRPC .</segment>
<segment id="18" parent="1015" relname="joint">In our research , we found the derivatives of natural 1,4-naphtoquinone compounds to be active in drug-resistant prostate cancer cells .</segment>
<segment id="19" parent="1020" relname="attribution">Preliminary data , however , have shown</segment>
<segment id="20" parent="1020" relname="span">that these substances are also rather cytotoxic for non-cancerous cells ,</segment>
<segment id="21" parent="20" relname="elaboration">suggesting undesired side effects in vivo .</segment>
<segment id="22" parent="1022" relname="span">Therefore , we utilized the Warburg effect</segment>
<segment id="23" parent="22" relname="purpose">in order to increase the selectivity of the compounds towards tumor cells .</segment>
<segment id="24" parent="1024" relname="span">We synthesized hybrid molecules ,</segment>
<segment id="25" parent="1025" relname="span">which contain selected natural 1,4-naphtoquinone moieties</segment>
<segment id="26" parent="25" relname="elaboration">conjugated with glucose residues via non-glycoside bond at C6 position .</segment>
<segment id="27" parent="1027" relname="span">The non-glycoside nature of the conjugates was chosen</segment>
<segment id="28" parent="1028" relname="span">in order to provide the highest affinity to glucose transporters</segment>
<segment id="29" parent="28" relname="elaboration">located in the cellular membrane .</segment>
<segment id="30" parent="1015" relname="joint">It is known</segment>
<segment id="31" parent="1032" relname="span">that the presence of free unsubstituted glycoside hydroxyl</segment>
<segment id="32" parent="31" relname="elaboration">( at C1 position )</segment>
<segment id="33" parent="1031" relname="same_unit">is important for the stabilization of hydrogen bonding interactions with GLUT-1</segment>
<segment id="34" parent="1015" relname="joint">and therefore is required for the successful cellular uptake of the sugar-conjugated molecules .</segment>
<segment id="35" parent="1015" relname="joint">In contrast , the hydroxyl at C6 position of glucose molecule is not relevant for the hydrogen bond interactions</segment>
<segment id="36" parent="1015" relname="joint">and therefore it ’s substitution may be more tolerable .</segment>
<segment id="37" parent="1015" relname="joint">In fact , the affinity of glucose with substituted C6-OH to GLUT-1 was reported to be almost equal to its unsubstituted analogues .</segment>
<segment id="38" parent="1039" relname="span">Therefore , instead of a conventional glycosylation reaction</segment>
<segment id="39" parent="38" relname="elaboration">( results in C1-substituted glucose )</segment>
<segment id="40" parent="1040" relname="span">we applied a new reaction of alkylation of 2-hydroxy-1,4-naphthoquinones with 6-deoxy-6-iodo-1,2:3,5-di-O- isopropylidene-α-D-glucofuranose</segment>
<segment id="41" parent="40" relname="elaboration">( results in a C6-substituted glucose ) .</segment>
<segment id="42" parent="1042" relname="span">This reaction was more efficient in comparison with transesterification reaction of 2-methoxy-1,4-naphthoquinones ,</segment>
<segment id="43" parent="42" relname="elaboration">which was recently discovered by us .</segment>
<segment id="44" parent="1044" relname="span">Thus , we synthesized a series of 6-(1,4-naphtoquinonyl)-D-glucose conjugates</segment>
<segment id="45" parent="44" relname="elaboration">containing diprotected , monoprotected , or unprotected glucose residues .</segment>
<segment id="46" parent="1046" relname="span">In line with our hypotheses the glucose-conjugated compounds revealed higher selectivity towards five human prostate cancer cell lines</segment>
<segment id="47" parent="46" relname="elaboration">compared with five non-cancerous lines .</segment>
<segment id="48" parent="1048" relname="span">The successful targeting of the Warburg effect by the newly synthesized glucose derivatives is strongly suggested by the following findings :</segment>
<segment id="49" parent="1050" relname="span">( a ) correlation of cytotoxicity and selectivity of the synthesized conjugates with higher expression of GLUT-1 in human prostate cancer cells ;</segment>
<segment id="50" parent="49" relname="elaboration">( b ) inhibition of cytotoxicity of the conjugates by addition of glucose to the media ;</segment>
<segment id="51" parent="1050" relname="elaboration">c ) ability of the compounds to inhibit a glucose uptake by cancer cells .</segment>
<segment id="52" parent="1053" relname="concession">In general , the binding of the quinone core with the glucose moiety lead to an increased water solubility and selectivity .</segment>
<segment id="53" parent="1053" relname="same_unit">However , at the same time it resulted in an absolute cytotoxicity decrease</segment>
<segment id="54" parent="55" relname="circumstance">when compared to methoxy derivatives ,</segment>
<segment id="55" parent="1054" relname="span">most probably due to the increased polarity of the molecule .</segment>
<segment id="56" parent="1057" relname="attribution">It should also be noted</segment>
<segment id="57" parent="1057" relname="joint">that normal prostate cells are known to have an active glycolysis</segment>
<segment id="58" parent="1058" relname="span">and also consume significant amount of glucose</segment>
<segment id="59" parent="58" relname="elaboration">( reviewed in ) .</segment>
<segment id="60" parent="1060" relname="span">Thus , these cells may also be affected by the Warburg effect</segment>
<segment id="61" parent="60" relname="elaboration">targeting therapeutics in vivo .</segment>
<segment id="62" parent="1062" relname="span">However , frequently patients with advanced prostate cancer have had local treatment for their primary tumors</segment>
<segment id="63" parent="62" relname="elaboration">leaving no vital tissue behind .</segment>
<segment id="64" parent="1063" relname="span">In the patients cytoreduction of the remaining prostate tissue maybe a pleasant side effect</segment>
<segment id="65" parent="64" relname="purpose">in order to avoid local complications .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1003" relname="preparation"/>
<group id="1003" type="multinuc" parent="1001" relname="span"/>
<group id="1004" type="span" parent="1003" relname="joint"/>
<group id="1005" type="multinuc" parent="4" relname="elaboration"/>
<group id="1006" type="multinuc" parent="1005" relname="same_unit"/>
<group id="1007" type="span" parent="1006" relname="joint"/>
<group id="1008" type="span" parent="7" relname="elaboration"/>
<group id="1012" type="span" parent="1003" relname="joint"/>
<group id="1014" type="span" parent="1003" relname="joint"/>
<group id="1015" type="multinuc" parent="1014" relname="span"/>
<group id="1017" type="span" parent="1015" relname="joint"/>
<group id="1019" type="span" parent="1015" relname="joint"/>
<group id="1020" type="span" parent="1019" relname="span"/>
<group id="1022" type="span" parent="1015" relname="joint"/>
<group id="1024" type="span" parent="1015" relname="joint"/>
<group id="1025" type="span" parent="24" relname="elaboration"/>
<group id="1027" type="span" parent="1015" relname="joint"/>
<group id="1028" type="span" parent="27" relname="purpose"/>
<group id="1031" type="multinuc" parent="1015" relname="joint"/>
<group id="1032" type="span" parent="1031" relname="same_unit"/>
<group id="1038" type="multinuc" parent="1015" relname="joint"/>
<group id="1039" type="span" parent="1038" relname="same_unit"/>
<group id="1040" type="span" parent="1038" relname="same_unit"/>
<group id="1042" type="span" parent="1015" relname="joint"/>
<group id="1044" type="span" parent="1015" relname="joint"/>
<group id="1046" type="span" parent="1015" relname="joint"/>
<group id="1048" type="span" parent="1015" relname="joint"/>
<group id="1049" type="span" parent="48" relname="elaboration"/>
<group id="1050" type="span" parent="1049" relname="span"/>
<group id="1052" type="span" parent="1015" relname="joint"/>
<group id="1053" type="multinuc" parent="1052" relname="span"/>
<group id="1054" type="span" parent="1053" relname="same_unit"/>
<group id="1056" type="span" parent="1015" relname="joint"/>
<group id="1057" type="multinuc" parent="1056" relname="span"/>
<group id="1058" type="span" parent="1057" relname="joint"/>
<group id="1059" type="multinuc" parent="1015" relname="joint"/>
<group id="1060" type="span" parent="1059" relname="contrast"/>
<group id="1061" type="multinuc" parent="1059" relname="contrast"/>
<group id="1062" type="span" parent="1061" relname="joint"/>
<group id="1063" type="span" parent="1061" relname="joint"/>
	</body>
</rst>
